MINCEUR 360 DRINK
Food supplement declared in France, declaration No 2024-3-116, decision dated 4 March 2024
MINCEUR 360 DRINK (EAFIT) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition.
- Brand
- EAFIT
- Food business operator placing the product on the market
- EQUILIBRE ATTITUDE
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Flacon
- Daily dose
- 30 ml ou 20 ml
- Directions for use
- 20 ou 30 ml selon objectif dans un grand verre d'eau
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Allergie aux dérivés salicylés, Calculs rénaux, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Insuffisance rénale, Maladie rénale, Nourrissons (moins de 1 an), Problèmes cardiaques, Problèmes de foie
- Objectives stated by the manufacturer (these are not authorised claims)
- Minceur / Brûleur, Minceur / Capteur, Minceur / Glycémie, Minceur / Ventre plat
- Flavourings
- Ananas
Declaration 303495, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Cynara scolymus L. | Feuille | Macérât aqueux | 228 mg |
| Silybum marianum (L.) Gaertn. | Fruit | Macérât aqueux | 228 mg |
| Cichorium intybus L. | Racine | Macérât aqueux | 228 mg |
| Elymus repens (L.) Gould | Rhizome | Macérât aqueux | 228 mg |
| Ribes nigrum L. | Feuille | Macérât aqueux | 228 mg |
| Tilia cordata Mill. | Aubier | Macérât aqueux | 228 mg |
| Hieracium pilosella L. | Parties aériennes | Macérât aqueux | 114 mg |
| Prunus cerasus L. | Pédoncule | Extrait sec aqueux | 57 mg |
| Cola nitida (Vent.) Schott et Endl. | Graine | Extrait fluide hydroalcoolique | 13.4 mg |
| Vitis vinifera L. | Marc | Extrait sec aqueux | 2.4 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Fructo-oligosaccharides | not declared |
| Caféine | not declared |
Additives
E412, E211, E202, E422, E955, E330
Other ingredients
Eau purifiée
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Réservé à l’adulte. Les compléments alimentaires doivent être utilisés dans le cadre d'un mode de vie sain et ne pas être utilisés comme substituts d'un régime alimentaire varié et équilibré. À tenir hors de la portée des jeunes enfants. Ne pas dépasser la dose journalière recommandée. Ce complément alimentaire est contre indiqué aux personnes souffrant d’insuffisance cardiaque ou rénale œdémateuses, d'allergie croisée connue en particulier à la famille des Asteraceae, d’obstruction biliaire ou d’autres troubles de la fonction biliaire.Complément Alimentaire avec édulcorant. Contient de la caféine (1,5 mg/30 ml). Déconseillé aux enfants de moins de 18 ans et aux femmes enceintes et allaitantes.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Silybum marianum (L.) Gaertn.
Read the warning, when it applies and the studies cited
MILK THISTLE - SILYBUM MARIANUM
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills et al. 2006).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Geier et al. 1990; Mironets et al. 1990).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Tilia cordata Mill.
Read the warning, when it applies and the studies cited
Linden - TILIA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; De Smet 1993).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Caféine
Read the warning, when it applies and the studies cited
CAFFEINE
Route of administration: Oral (Higdon and Frei 2006)
Cautions and warnings
Applies to products providing 100 mg to 400 mg caffeine, per day1.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have high blood pressure or glaucoma (Cornelis and El-Sohemy 2007, Chandrasekaran et al. 2005, Noordzij et al. 2005, Avisar et al. 2002, Arya et al. 2000, Jee et al. 1999, Creighton and Stanton 1990).
7 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
1Note: This statement is also required at subtherapeutic quantities for products providing 40 mg or more caffeine per day from all sources for Class II and III applications.
Applies to products providing more than 300 mg caffeine, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant, breastfeeding, or attempting to conceive (Nawrot et al. 2003).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 400 mg or more caffeine, per day.
When using this product avoid taking other health products, foods or beverages that contain caffeine and/or increase blood pressure (FDA 2023; Bui et al. 2006; Bouchard et al. 2005; Haller et al. 2005; NIH 2004; Berardi et al. 2002; Vahedi et al. 2000; Zimmerman 1992).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Applies to products providing more than 400 mg caffeine per day.
Do not use if you have high blood pressure or glaucoma (Cornelis and El-Sohemy 2007, Chandrasekaran et al. 2005, Noordzij et al. 2005, Avisar et al. 2002, Arya et al. 2000, Jee et al. 1999, Creighton and Stanton 1990).
7 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if hypersensitivity/allergy occurs (Infante et al. 2003; Hinrichs et al. 2002).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 200 mg or more caffeine, per day.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms such as chest pain and irregular heartbeat occur (Higgins and Babu 2013).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing more than 400 mg caffeine, per day.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if nervousness, anxiety, insomnia, tremor and/or headache occur (IOM 2001, Zhang 2001, Sawynok 1995).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: All products except those making a diuretic claim1.
When using this product diuretic effect may occur.
1Note: This statement is also required at subtherapeutic quantities for products providing 40 mg or more caffeine per day from all sources for Class II and III applications.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- MINCEUR 360 DRINK EAFIT, declared in 2025 : different composition: 0 ingredient(s) added, 2 missing
Brand : EAFIT
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.